| Factor Information | |
|---|---|
| Data ID | 645 |
| Factor | post-treatment MPI T/B ratio in PAH patients(moderate/severe:mild) |
| Description | N/A |
| Biomarker | NA |
| Classification | A6 (clinical factor - other) |
| Association | |
|---|---|
| Application | diagnosis |
| Objective | CHD patients with moderate/severe PAH |
| p Value | 0.046 |
| Conclusion | Receiver operating characteristics curves showed that the diagnostic performance of MPI T/B ratio in moderate/severe PAH patients was significant. |
| Risk Factor | unknown |
| CHD Type | |
|---|---|
| ID | 472 |
| CHD Type | isolated CHD |
| CHD Subtype | VSD with PAH/ASD with PAH/PDA with PAH |
| Reference | |
|---|---|
| PMID | 29177254 |
| Year | 2017 |
| Title | Semi-quantitative assessment of pulmonary arterial hypertension associated with congenital heart disease through myocardial perfusion imaging |
| Sample | ||
|---|---|---|
| Population | adolescent, adult | |
| Source | data | |
| Region | China, Wuhan | |
| Method | ROC analysis | |
| Race | Asian | |
| Disease History | N/A | |
| Treatment History | medicine and operation intervention | |
| Group | moderate/severe PAH patients(Treatment) | mild PAH patients(Control) |
| Number | N/A | N/A |
| Age | N/A | N/A |
| Gender (Male: Female) | N/A | N/A |
| Marker Level | N/A | N/A |
